Todd Foley - Jun 24, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
Director
Signature
/s/ Todd Foley
Stock symbol
RPTX
Transactions as of
Jun 24, 2021
Transactions value $
-$423,620
Form type
4
Date filed
6/28/2021, 04:08 PM
Previous filing
Jun 23, 2021
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale -$90.4K -2.7K -0.12% $33.53 2.29M Jun 24, 2021 See Footnote F1, F2, F3, F4
transaction RPTX Common Shares Sale -$333K -9.94K -0.43% $33.51 2.28M Jun 25, 2021 See Footnote F1, F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on 3/31/2021.
F2 The shares were sold as follows: 2,607 by MPM BioVentures 2014, L.P. ("BV 2014") and 90 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.11 to $33.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares are held as follows: 2,080,922 by BV 2014, 135,843 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 71,625 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F5 The shares were sold as follows: 9,612 by BV 2014 and 331 by AM BV2014.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The shares are held as follows: 2,071,310 by BV 2014, 135,843 by BV 2014(B) and 71,294 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.